BlueRock Therapeutics advanced bemdaneprocel, an investigational cell therapy, to a registrational Phase III clinical trial for Parkinson's disease.
BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases
BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. The company’s cell+gene platform enables the creation, manufacture, and delivery of authentic cell therapies with engineered functionality by simultaneously harnessing pluripotent cell biology and genome editing.